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The 2 studies of young adult cancer survivors highlighted in this issue of Cancer are exemplars of a body of survivorship
research that has emerged since Mullan’s seminal article in the New England Journal of Medicine in 1985, which acknowl-
edged a trajectory of survivorship that initiates at diagnosis and continues through extended phases of treatment and transi-
tions into off-treatment survival.1 Both works evaluated patient-reported outcomes and thus provide insight into a patient-
centered experience of cancer and its effect on the lives of adolescents and young adults (AYAs). Patient-centered perspectives
on cancer survivorship are useful in informing the development of clinical care programs and research. They reflect the prefer-
ences, values, beliefs, and concerns of patients, which is knowledge necessary for equalizing the doctor–patient relationship,
achieving shared decision-making, and perhaps contributing to a greater likelihood that patients will adopt provider instruc-
tions and adhere to and complete therapy. The studies by Salsman et al and Champion et al illuminate issues of particular
relevance for an age-defined population of AYAs. Their findings are consistent with a small but emerging body of AYA survi-
vorship literature and also stimulate thought related to methodological considerations for future AYA research.
Existing evidence suggests that patients’ subjective experiences are better predictors of quality of life (QOL) out-
comes relative to objective conditions.2-5 Few studies offer data to support the assertion that clinical characteristics such as
cancer type or its associated severity or prognosis for survival explains variability in psychosocial outcomes. For example, a
longitudinal study of 215 AYAs aged 15 to 39 years indicated that those with cancers that have 80% to 100% expected 5-
year survival rates (eg, testicular cancer, Hodgkin’s disease) were just as likely to report psychological distress at 1-year
postdiagnosis as were those with worse 5-year survival rates.6 Thus, Salsman and colleagues had no a priori expectations
for differences in outcomes by cancer type and were able to test a critical question related to time beyond end of therapy
and its relationship to health-related QOL (HRQOL) in a large heterogeneous sample of AYAs. Given the relative rarity
of cancer in teenagers and young adults, restricting studies of psychosocial outcomes to just 1 or 2 cancer types to control
for presumed physiological effects related to cancer type unnecessarily burdens investigators. They require extended peri-
ods of time and/or large recruitment sources (multiple institutions or registries), and thus negatively affect the feasibility
of conducting AYA trials with significant numbers of patients to test hypotheses.
Findings from the study by Champion et al raise important issues related to sex, sexuality, and the interdependence
of relationships, emotional health, and physical functioning. As adolescents and young adults enter into intimate, emo-
tional, and sexual relationships, perhaps for the very first time, they do not expect illness. The words so often spoken at the
altar of marriage or commitment, “In sickness and in health, until death do us part,” are rarely acknowledged by young
people as a possibility as they consider other hopes and dreams for the future. Most AYAs, within the context of budding
romances and new commitments, lack the skills necessary to navigate cancer and its challenges to relationships. Indeed,
Champion et al reported impacts of cancer on mental health status, sexual functioning, physical functioning, and fatigue
to be salient for AYAs, and significantly more so when compared to older patients with cancer. These factors are all inter-
dependent and must be considered together when determining best approaches for supportive care; otherwise, interven-
tions become piecemeal. For example, addressing sleep problems only by prescribing medication ignores attention to
other known psychological or social correlates of sleep difficulties. Relying solely on pharmacological intervention for
treating anxiety, depression, or adjustment disorders in patients with cancer, without considering psychotherapeutic
options, flies in the face of evidence suggesting that psychotherapeutic and cognitive-behavioral interventions are
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efficacious.7,8 The work of Champion et al suggests the
need for multifaceted, multipronged, multilevel research
and interventions to improve QOL for AYA patients with
cancer.
The studies by Salsman et al and Champion et al
also suggest points of consideration regarding how we
should be conducting AYA research. Specifically, their
findings are salient to discussions of what the upper and
lower age bounds could or should be to define an AYA
population. Their findings also raise unique methodologi-
cal issues related to cancer genetics and assessments of
AYA family composition, gender identification, marital
and relationship status, and sex and sexuality.
AYA Age Range
Of course, there are developmental differences within the
15- to 39-year age range, the convention for defining
AYAs in the United States,9,10 and these developmental
differences can confound study findings if age group suba-
nalyses are not conducted. For example, we cannot draw
conclusions about an age-bounded AYA population from
the study by Champion et al, because they compared
women under 45 years of age to older women. In contrast,
Salsman et al did conduct subanalyses within the 15- to
39-year age cohort and found statistically significant dif-
ferences in HRQOL between 30- to 39-year-olds and 25-
to 29-year-olds. The explanations for these differences are
psychological and social in nature, and suggest that 30- to
39-year-old “AYAs” may be more different from, than
similar to, younger AYAs. Indeed, the developmental
tasks, needs, and concerns for young people in their 30s
are different from those of younger people in their teens
and 20s. The continued inclusion of older AYAs aged 30
to 39 years in study samples may confound conclusions
drawn about AYAs in general. The Salsman et al study
findings appear to support a more narrow age range for an
AYA population; however, they contrast with other stud-
ies in which no age differences were observed in emotional
and mental health outcomes for similarly aged AYAs.6,11
Further research involving within-group as well as
between-group comparisons is needed, as are more inves-
tigations of instrumentation and the possibility that use of
standardized psychometric instruments not tested in an
AYA population are producing spurious results.
Genetics
Although Champion and colleagues iterate that young
women can and do get breast cancer, we also know that
younger patients with breast cancer are more likely than
older breast cancer patients to be diagnosed with
metastatic disease and more likely to die from breast can-
cer.12 Moreover, the incidence of triple-negative breast
cancer among younger women and particularly younger
African American women, along with unique protein
expression patterns and poorer survival, implicates vary-
ing gene-environment interactions with respect to age and
race/ethnicity.13 An emerging field of epigenetics suggests
that social and environmental stressors, including poverty
and racial discrimination, have the potential to activate
(or deactivate) genetic mechanisms and may place African
American women in particular at increased risk for dis-
ease. Further research is needed to determine why younger
women, and predominantly African American women,
are diagnosed with this more deadly form of breast cancer,
and to derive effective therapies.
Family Composition, Gender, Marital/
Relationship Status, and Sex and Sexuality
The authors of both studies identified limitations of their
studies in terms of selection bias; however, there is an
unmentioned aspect of selection bias that is of particular
relevance to the AYA population, and it has to do with how
investigators collect self-report data on family composition,
gender, marital/relationship status, and sex and sexuality.
Today’s AYAs are of a generation openly exposed to
diverse family compositions. When surveying AYA
patients about their parents and where they live, we must
acknowledge that some young people are raised or live
with just one parent or go back and forth between
divorced or separated parents. Some AYAs have 2 moth-
ers; some have 2 fathers. Some young people live tempo-
rarily with extended family members, sometimes to avoid
parental abuse, neglect, alcoholism, or drug addiction. For
some, living conditions are unstable to the point at which
life is more about where you “stay at” and less so about
“where you live.” When asking AYAs where they live and
with whom, survey response categories need to reflect the
multiple and varied options that are relevant to them.
Similarly, male and female response categories for
gender do not adequately reflect the realities of the human
biological condition and may reflect investigators’ own
biases and ignorance in distinguishing biological sex and
gender identification. When we include gender as a cate-
gory in a survey, why? Are we suggesting that gender as bi-
ological sex assignment is relevant to our research
question? Or is the respondent’s gender identity—one’s
own internal, personal sense of being a man or a woman
(or as someone outside of that gender binary)—more rele-
vant? The answers to these questions guide us differently.
If we think that one’s gender identity is somehow relevant
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to the research, we must consider a universe of possible
and mutually exclusive response options (male, female,
transgender); otherwise, we increase the risk of bias by ei-
ther excluding a portion of the population of interest, or
else lessening the reliability of our findings by forcing per-
sons to select a gender identity category that is not a true
reflection of who they are.
The same holds true for questions (eg, marital sta-
tus) that explicitly or implicitly assess sexual orientation: a
person’s enduring physical, romantic, and/or emotional
attraction to another person (eg, straight, gay, lesbian,
bisexual). Given that AYAs are at a time in their life when
they are trying to make sense of themselves and their bur-
geoning sexuality, we enhance our own potential for
deriving relevant knowledge about AYAs and the impact
of cancer in their life if we use inclusive language and cate-
gories in our science. Given the existence of gay, lesbian,
and bisexual AYAs diagnosed with cancer, we limit the
rigor of our science by using language and response cate-
gories for collecting demographic data that excludes por-
tions of the population and thus diminishes the
probability of having representative samples. Questions
related to marriage or relationship status must include sci-
entifically valid response options that capture the realities
of human sexual experience and minimize response bias.
As we proceed to advance an AYA research agenda, I
offer one last comment having social and political impli-
cations. Although disparate survival and quality of life
outcomes for AYAs have been reported, we must be care-
ful about calling AYAs a “medically underserved group
similar to racial and ethnic minorities.” Like racial and
ethnic minorities, AYAs have been subject to a lack of
attention that is partially attributable to the organization
of a health care service delivery system. Unlike racial and
ethnic minority groups, however, the disparities in care
and outcomes for AYAs are not rooted in hundreds of
years of exposure to racism and discrimination. In consid-
ering submission of AYA research proposals to grant-
funding mechanisms for “disparities research,” we must
be sensitive to a politics of research when comparing an
AYA research agenda to one addressing disparate out-
comes among minority groups (defined not only by race/
ethnicity but also by sexual orientation or gender), in
which those disparities are rooted in institutionalized dis-
crimination and social oppression. More importantly,
however, all investigators involved in social and behavioral
science and research need to recognize what unites us
rather than what divides us. Together, we must focus our
energies on collaboration and influencing the institutions
responsible for allocating dollars for psychosocial and be-
havioral research, including disparities research however
defined, and away from competing against one another
for a diminishing piece of the research funding pie.
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